RxDoctor Payments Data

Matthew Parmenter, DPM

Podiatrist · Linton, INNPI 1013902089

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Stryker at 48.6% of the total. Reporting peaked in 2022 at $1,267 and has fallen 89.5% since, to $133 in 2025.

$2,909in general payments, 2019–2025

Across 82 payments — averaging $35.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Cook Medical LLC$402
  • Pfizer$146
  • Smith+Nephew$143
  • Kerecis Limited$101
  • AbbVie$91
  • plus $611 from 21 others

What the payments were for

  • Consulting fees$40014%
  • Travel & lodging$91131%
  • Food & beverage$1,58655%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,909 in reported general payments places this provider in the 65th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$129,089
Medicare patients
532
Services billed
2,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$6,166
Ketoconazole96$2,098
Mupirocin119$867
Gabapentin62$740
Cefdinir45$700
Triamcinolone Acetonide107$572
Gentamicin Sulfate18$500
Ampicillin Trihydrate15$359
Doxycycline Hyclate29$271
Minocycline Hcl15$229
Levofloxacin31$227
Allopurinol61$204
Pentoxifylline12$153
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$135
Ciprofloxacin Hcl12$123

Paid to pharmacies, not to this prescriber.

Other podiatrist in Linton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →